Clinical interests in thoracic and gastrointestinal (GI) cancers including neuroendocrine tumours (NETs) and mesothelioma.
Stephen has major clinical interests and experience in medical oncology, in thoracic and gastrointestinal (GI) cancers, including neuroendocrine tumours (NETs) and mesothelioma. He also has a special clinical interest in cancer pharmacology and cancer-associated inflammation.
Stephen is an empathic clinician with over 30 years clinical experience in Australia which came after completion of a PhD at the Royal Marsden Hospital in the UK, the largest cancer centre in Europe.
Stephen previously worked at Westmead and Nepean Hospitals (1994-95) plus Concord and Royal Prince Alfred Hospitals (1995-2010). He then returned to the North Shore Campus in 2010 to help collaborate and investigate their service strategies aiming to offer leading cancer survival advantages in Australia.
Stephen previously worked at Westmead and Nepean Hospitals (1994-95) and Concord and Royal Prince Alfred Hospitals (1995-2010), and then returned to the North Shore Campus in 2010 to help further enhance and investigate their Australian leading cancer survival advantages.
Stephen’s contributions to medicine have been recognised with awards including the Order of Australia (OAM) for services to medicine in the disciplines of oncology and pharmacology, received in 2011. Further, in 2016 he was awarded the Medical Oncology Group of Australia Cancer Achievement Award. In addition, Stephen is committed to educating junior clinicians and cancer scientists. In 2020, he was awarded the John Sands Medal, by the Royal Australasian College of Physicians for his work in supporting the education and development of young Medical Oncologists and physicians in general.
As a patient in Stephen’s care, you can be sure you’re being cared for by a leading medical oncologist working as part of a dedicated multidisciplinary team.
- In addition to his clinical work, Stephen is a dedicated patient advocate and researcher. His research has been supported by over $28 million in funding, producing a number of strongly-cited publications.
- Stephen’s clinical and research interests have included all the issues that are important to cancer patient well-being including new treatments, nutrition, complementary therapies, including medicinal cannabis and exercise.